why is moderna stock down today
Shares of Moderna are down by 7 today as higher Treasury yields put significant pressure on high-growth stocks. Their MRNA share price forecasts range from 7700 to 30400.
/TopStocksThroughDec.32021-c74207f8fbae4a0a9aa7dd035d893871.png)
The Top And Bottom 5 Stocks Of 2021
Moderna reported revenue of 5 billion and earnings of 770 per share.
. Moderna stock is already down by more than 70 from the highs that were reached back in August 2021 but there is no rush to buy the stock as traders question the future of. Amid the volatility many investors sought shelter in Moderna and other vaccine stocks on the belief that. 12 analysts have issued 12-month price objectives for Modernas shares.
In 2022 Moderna is expected to report earnings of 271 per share so the stock is trading at roughly 12 forward PE which is cheap for the current market environment. Shares of Moderna are down by 7 today as higher Treasury yields put significant pressure on high-growth stocks. 1 day agoShares of Moderna MRNA 840 jumped 84 on Friday after rival drugmaker Pfizer PFE 475 said it intends to drastically increase the price of its COVID-19 vaccine next year.
What happenedShares of Moderna NASDAQ. Moderna is hoping to offset this downturn in COVID vaccine sales by using its mRNA technology to develop new drugs targeted at other diseases such as influenza HIV and. There is a broad sell-off in the market and SP 500 is down by.
This uncertainty helped to drive the financial markets lower in recent weeks. Although it wasnt down by as much as the SP 500 index Moderna was still off by almost 2 in late afternoon trading. Shares of Moderna gained strong downside momentum after the company released its third-quarter report.
August 10 2021 842 AM 2 min read. Analyst estimates for Modernas earnings in 2021 have recently moved lower and now analysts expect that the company will report earnings of 2931 per share this year. Moderna Stock Falls As Traders Take Profits At All.
Shares of several top COVID-19 vaccine makers were sinking on Tuesday. Positive news from a top rival was a key reason why. On average they anticipate the.
MRNA were down by 53 as of 125 pm. The company announced a long-term collaboration with Thermo Fisher. There is a broad sell-off in the market and SP 500 is down by.
Why Moderna Stock Is Down By 5 Today. The 55 analysts offering price forecasts for Moderna have a median target of 19980 with a high estimate of 46300 and a low estimate of 6000. Currently analysts expect that Moderna will report earnings of 2589 per share in 2021 and earnings of 2647 per share in 2022 so the stock is trading at roughly 9 forward PE.
Moderna reported revenue of 5 billion and earnings of 770 per share. Shares of Moderna gained downside momentum after the company announced a 15-year strategic collaboration agreement with Thermo Fisher Scientific which will produce the. Shares of Moderna gained strong downside momentum after the company released its third-quarter report.
Analysts expect that Moderna will report earnings of 2785 in 2022 so the stock is trading at roughly 8 forward PE which is certainly cheap for the current market environment. PFE stock was down 27 as of 1109 am. Shares of Moderna gained downside momentum after the company announced a 15-year strategic collaboration agreement with Thermo Fisher Scientific which will produce the.
Analysts expect that Moderna will report earnings of 2785 in 2022 so the stock is trading at roughly 8 forward PE which is certainly cheap for the current market environment.
Moderna Stock Down After Positive Booster News
Moderna Stock Is A Winner But How Much Higher Can It Go
Phase Ii Trials Starting Any Day So Why Is Moderna S Stock Down 40
Why Moderna Stock Is On Fire Today The Motley Fool
Moderna S Stock Sharply Down After Disappointing Earnings The Boston Globe
Moderna Paypal And More Wednesday Stock Market Movers Barron S
How Moderna Nearly Lost The Race To Develop A Covid 19 Vaccine Stat
Moderna Inc Mrna Stock Price News Google Finance
Moderna Taps 1 34b Stock Offering To Bankroll Its Promising Covid 19 Vaccine Fierce Pharma
Why Are Moderna Executives Selling Stock While Developing A Coronavirus Vaccine Npr
Moderna Covid 19 Vaccine Progress Sends Stock Markets Higher Cbc News
Moderna Inc Home Facebook
Moderna Mrna Us Covid 19 Coronavirus Vaccine Production Bloomberg
Stock Market Today Dow Rose As Moderna Slumped Again Barron S
Another Way To Think About The Best Covid Vaccine The Atlantic
Why Moderna Stock Is Bolting Higher Today The Motley Fool
Moderna Slashes Covid Vaccine Outlook As Focus Shifts To Global Markets S P Global Market Intelligence
Moderna On Twitter Breaking The Fda Has Approved The Biologics License Application Bla For Spikevax Covid 19 Vaccine Mrna To Prevent Covid19 In Individuals 18 Years Of Age And Older Https T Co Ska7sybalr Twitter
Moderna Nears Its First Ever Fda Authorization For Its Covid 19 Vaccine Marketwatch